Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Healthcare Pharmacy topic
No spam. Unsubscribe anytime.
Committee advances amendments to Wyoming Pharmacy Act to expand pharmacist care and lower immunization age
Summary
The Labor Health committee reviewed and adopted committee edits to Senate File 121, clarifying pharmacist care services, allowing pharmacists to decline participation under board rules, and lowering the minimum age for pharmacist-administered immunizations from 7 to 3; the committee voted 5–0 to advance the bill.
Get email alerts on the Healthcare Pharmacy topic
No spam. Unsubscribe anytime.
The Labor Health committee advanced Senate File 121, a package of amendments to the Wyoming Pharmacy Act, after adopting a committee amendment and voting 5–0 to send the measure out of committee.
Committee members reviewed a line-by-line amended bill that clarifies pharmacist responsibilities for administering prescriptions, counseling and assessing patients, and explicitly recognizes ‘pharmacist care services’ under pharmacy rules. Matt Martin of the Board of Pharmacy told the committee the bill will renumber the existing statutory language in 33-24-124 to subsection (a) and add new subsections (b) and (c), not repeal the existing statute.
The amendment package includes a change to the minimum age for pharmacist-administered immunizations, lowering it from 7 to 3 years old, and adds language specifying the continued use of programs, technologies and education to improve patient safety. The draft also preserves drug-utilization review functions — checking for therapeutic duplication, adverse interactions and other safety concerns — as part of pharmacist care services.
During questioning, Senator Scott pressed whether the provision allowing pharmacists to ‘assess the patient’ covers pharmacists reconciling conflicting prescriptions from multiple prescribers. Matt Martin responded that those activities are typically covered by pharmacist care services and drug-utilization review, citing checks for therapeutic duplication and safety concerns.
A committee amendment was moved by Senator Steinmetz and seconded by Senator Hutchings and was adopted by the committee. The roll call on the final, amended Senate File 121 recorded an absentee 'aye' from Senator Crump and recorded 'aye' votes from Senators Hutchings, Scott, Steinmetz and Chairman Brennan, producing a 5–0 tally in favor of advancing the bill.
Senator Scott urged the Board of Pharmacy and the medical society to coordinate and to return to the committee if real-world implementation reveals unintended consequences that require legislative fixes. The committee closed the meeting with thanks to members and staff and noted it will take the next day off.
The committee’s action advances the bill to the next step in the legislative process; no further committee votes were recorded in this meeting.

